Calliditas Therapeutics AB Gains 73.92%
Tue, May 28, 2024 at 07:15 PM
Calliditas Therapeutics AB (CALT:NASDAQ) soared at $37.95, representing a gain of 73.9%. On Tue, May 28, 2024, CALT:NASDAQ hit a New 2-Week High of $37.95. The stock appeared on our News Catalysts scanner on Tue, May 28, 2024 at 12:27 PM in the 'BIOTECH' category. From Tue, May 14, 2024, the stock recorded 44.44% Up Days and 30.00% Green Days
About Calliditas Therapeutics AB (CALT:NASDAQ)
Calliditas Therapeutics AB is a biopharmaceutical company in Sweden. The company is engaged in the provision of pharmaceutical products for patients with niche indications.
Top 10 Gainers:
- F45 Training Holdings Inc. (FXLV:NYSE), 147.93%
- AERWINS Technologies Inc Com (AWIN:NASDAQ), 143.09%
- Sharps Technology Inc. (STSS:NASDAQ), 141.44%
- SRAX, Inc. (SRAX:NASDAQ), 125%
- Insmed Incorporated (INSM:NASDAQ), 118.45%
- Schmitt Industries, Inc. (SMIT:NASDAQ), 117.65%
- Logistic Properties of the Americas (LPA:NYSEMKT), 98.58%
- Scopus BioPharma Inc. (SCPS:NASDAQ), 90.91%
- Visionary Education Technology Holdings Group Inc. (GV:NASDAQ), 80.5%
- Calliditas Therapeutics AB (CALT:NASDAQ), 73.92%